132 related articles for article (PubMed ID: 29029435)
21. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.
Xie J; Wang CH
Pharm Res; 2005 Dec; 22(12):2079-90. PubMed ID: 16132339
[TBL] [Abstract][Full Text] [Related]
22. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
[TBL] [Abstract][Full Text] [Related]
23. Cationic core-shell nanoparticles with carmustine contained within O⁶-benzylguanine shell for glioma therapy.
Qian L; Zheng J; Wang K; Tang Y; Zhang X; Zhang H; Huang F; Pei Y; Jiang Y
Biomaterials; 2013 Nov; 34(35):8968-78. PubMed ID: 23953782
[TBL] [Abstract][Full Text] [Related]
24. Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.
Tivnan A; Heilinger T; Ramsey JM; O'Connor G; Pokorny JL; Sarkaria JN; Stringer BW; Day BW; Boyd AW; Kim EL; Lode HN; Cryan SA; Prehn JH
Oncotarget; 2017 Mar; 8(10):16605-16620. PubMed ID: 28178667
[TBL] [Abstract][Full Text] [Related]
25. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
26. Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation.
Ananta JS; Paulmurugan R; Massoud TF
Neurol Res; 2016 Jan; 38(1):51-9. PubMed ID: 26905383
[TBL] [Abstract][Full Text] [Related]
27. Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts.
Madala HR; Punganuru SR; Ali-Osman F; Zhang R; Srivenugopal KS
Oncotarget; 2018 Jan; 9(3):3459-3482. PubMed ID: 29423059
[TBL] [Abstract][Full Text] [Related]
28. Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors.
Bhujbal SV; de Vos P; Niclou SP
Adv Drug Deliv Rev; 2014 Apr; 67-68():142-53. PubMed ID: 24491927
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment.
Belhadj Z; Zhan C; Ying M; Wei X; Xie C; Yan Z; Lu W
Oncotarget; 2017 Sep; 8(40):66889-66900. PubMed ID: 28978003
[TBL] [Abstract][Full Text] [Related]
30. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J
Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticle formulation of ormeloxifene for pancreatic cancer.
Khan S; Chauhan N; Yallapu MM; Ebeling MC; Balakrishna S; Ellis RT; Thompson PA; Balabathula P; Behrman SW; Zafar N; Singh MM; Halaweish FT; Jaggi M; Chauhan SC
Biomaterials; 2015; 53():731-43. PubMed ID: 25890768
[TBL] [Abstract][Full Text] [Related]
32. Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer.
Jain A; Jain A; Garg NK; Tyagi RK; Singh B; Katare OP; Webster TJ; Soni V
Acta Biomater; 2015 Sep; 24():140-51. PubMed ID: 26116986
[TBL] [Abstract][Full Text] [Related]
33. Salinomycin encapsulated nanoparticles as a targeting vehicle for glioblastoma cells.
Tığlı Aydın RS; Kaynak G; Gümüşderelioğlu M
J Biomed Mater Res A; 2016 Feb; 104(2):455-64. PubMed ID: 26476239
[TBL] [Abstract][Full Text] [Related]
34. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.
Loureiro JA; Gomes B; Fricker G; Coelho MAN; Rocha S; Pereira MC
Colloids Surf B Biointerfaces; 2016 Sep; 145():8-13. PubMed ID: 27131092
[TBL] [Abstract][Full Text] [Related]
35. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J
Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590
[TBL] [Abstract][Full Text] [Related]
36. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
[TBL] [Abstract][Full Text] [Related]
37. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
[TBL] [Abstract][Full Text] [Related]
38. Drug encapsulated aerosolized microspheres as a biodegradable, intelligent glioma therapy.
Floyd JA; Galperin A; Ratner BD
J Biomed Mater Res A; 2016 Feb; 104(2):544-52. PubMed ID: 26238392
[TBL] [Abstract][Full Text] [Related]
39. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
Amin FU; Shah SA; Badshah H; Khan M; Kim MO
J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
[TBL] [Abstract][Full Text] [Related]
40. Albumin-Encapsulated Platinum Nanoparticles for Targeted Photothermal Treatment of Glioma.
Chang C; Wang C; Zhang C; Li L; Zhang Q; Huang Q
J Biomed Nanotechnol; 2019 Aug; 15(8):1744-1753. PubMed ID: 31219025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]